Skip to content

Paolo Deluca

12 papers in the library · 561 citations · publishing 2005-2025

Papers

Sort Most recent Most cited

“Becoming Your Own Psychologist”: Novel Psychoactive Substances (NPSs) for Mood and Anxiety Disorder Self-Medication

Psychoactives August 20, 2025 Tayler Holborn, Fabrizio Schifano, Emma E Smith et al. 1 citation

Numerous individuals suffer from mental health issues including depression and anxiety, resulting in substantial societal burden. Data suggests individuals are choosing to self-medicate with Novel Psychoactive Substances (NPS); however, this phenomenon is poorly understood. We aimed to investigate which NPS are being used to self-medicate, evaluate their perceived effectiveness and examine...

DOI: 10.3390/psychoactives4030028 (opens in new tab) Anxiety Mood Clinical psychology Psychotherapist

Self-medication with Novel Psychoactive Substances (NPS): a Systematic Review

International Journal of Mental Health and Addiction November 28, 2023 Tayler Holborn, Robert L. Page, Fabrizio Schifano et al. 5 citations

Abstract Currently, novel psychoactive substance (NPS) use presents a challenging issue for authorities. To effectively tackle the use of NPS, a deeper understanding of the motivations of those who use NPS is required. Evidence suggests that a subset of NPS users declare their use as ‘self-medicating’; however, there is a paucity of research in this area. The aim of this review is to provide an...

No prescription? No problem: A qualitative study investigating self-medication with novel psychoactive substances (NPS).

International Journal of Drug Policy August 1, 2023 Tayler Holborn, Fabrizio Schifano, Paolo Deluca 15 citations

The proliferation of Novel Psychoactive Substances (NPS) presents a challenge for global drug policy. The ease of online drug purchase and the emergence of the dark web have created new avenues for the growth of NPS. Despite the global nature of this issue, limited research has examined motivations of use. These include perceived safety or convenience, an interest in novel pharmacology and...

Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine

Human Psychopharmacology: Clinical and Experimental March 1, 2012 Ornella Corazza, Fabrizio Schifano, Pierluigi Simonato et al. 157 citations

On the basis of the material available both in the scientific literature and on the web, this paper aims to provide a pharmacological, chemical and behavioural overview of the novel compound methoxetamine. This is a dissociative drug related to ketamine, with a much longer duration of action and intensity of effects. A critical discussion of the availability of information on the web of...

DOI: 10.1002/hup.1242 (opens in new tab) Phenomenon The internet Scientific literature Recreation +8

Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly

Current reviews in clinical and experimental pharmacology May 1, 2011 Ornella Corazza, Fabrizio Schifano, Magı́ Farré et al. 98 citations

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute...

DOI: 10.2174/157488411796151129 (opens in new tab) Phenethylamines Hallucinogen The internet Psychoactive substance +7

Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

Psychopharmacology April 2011 Fabrizio Schifano, Antonio Albanese, Suzanne Fergus et al.

Recently, those substances deriving from the active ingredient of the Khat plant, cathinone, have been rising in popularity. Indeed, 4-methylmethcathinone (mephedrone; 'meow meow' and others) has been seen by some as a cheaper alternative to other classified recreational drugs. We aimed here at providing a state-of-the-art review on mephedrone history and prevalence of misuse, chemistry,...

Mass‐information: mephedrone, myths, and the new generation of legal highs

Drugs and Alcohol Today August 30, 2010 Zoe Davey, Ornella Corazza, Fabrizio Schifano et al. 30 citations

The market in licit recreational drugs is continuing to grow, both in the UK and elsewhere, and the internet has been acknowledged as a key factor in enabling this rapid expansion over the last few years. This is particularly true of the recent rise in popularity of the substance mephedrone (4-methylmethcathinone) and related cathinones. Keeping up to date with these new drugs and emerging...

DOI: 10.5042/daat.2010.0467 (opens in new tab) Mephedrone Misinformation Popularity Internet privacy +10

Psychoactive drug or mystical incense? Overview of the online available information on Spice products

International Journal of Culture and Mental Health December 1, 2009 Fabrizio Schifano, Ornella Corazza, Paolo Deluca et al. 79 citations

The aim of the study was to foster the collection and analysis of data from web pages related to information on the consumption, manufacture and sale of Spice products, a brand name for an herbal smoking blend, sold as legal substitute for cannabis. The Google search engine was used to carry out an 8-language qualitative assessment of information available on Spice products in a sample of about...

DOI: 10.1080/17542860903350888 (opens in new tab) Cannabis Spice Popularity World wide web +1

Searching the Internet for drug-related web sites: analysis of online available information on ecstasy (MDMA).

American Journal on Addictions 2007 Paolo Deluca, Fabrizio Schifano

Although the Internet is a growing source of information on MDMA/ecstasy, no studies so far have investigated the level and quality of ecstasy information available to the typical Web user. In the present study, 280 Web sites were identified and analyzed; 50.4% had an anti-drug approach, 16.2% a harm reduction approach, and 24.8% a pro-drug approach. MDMA pro-drug Web sites appeared...

[Salvia divinorum--representation of a new drug in the Internet].

Das Gesundheitswesen May 1, 2006 Holger Siemann, Michael Specka, Fabrizio Schifano et al. 10 citations

The German pages of the Internet were searched for the presence of the hallucinogenic herbal drug Salvia divinorum, which is not dealt with in current addiction medicine or psychiatric text books. The investigation is part of the EU sponsored project "Psychonaut" as preparatory work for the development of an Internet-based early warning system. The first 100 websites of the search using "Salvia...

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994–2003)

Journal of Psychopharmacology March 30, 2006 Fabrizio Schifano, John Corkery, Paolo Deluca et al. 96 citations

In the last decade, a global trend of escalating ecstasy (MDMA, MDA, MDEA, MBDB) use was observed. Mentions on medical death certificates, last year's ecstasy use, number of drug offenders, seizures, prices and dosage levels figures were used for this descriptive and correlational study. Figures (1994ñ2003) were taken from the UK General Mortality Registers, from the Home Office Statistical...

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').

Journal of Psychopharmacology November 1, 2005 Fabrizio Schifano, Paolo Deluca, Lisa Agosti et al. 70 citations

2C-T-7 ('Blue Mystic'), an illicit compound which shows similarities with MDMA and other designer drugs, has been only occasionally identified in the EU, but discussion on the Internet between experimenters has recently grown significantly. We aimed at collecting together in a review the available information on 2C-T-7, both at the cyber and at the street market level. 2C-T-7 was first...

DOI: 10.1177/0269881105056660 (opens in new tab) Full text (opens in new tab) Online drug trends Digital drug trends Internet drug trends Cyber drug trends +16